CAMBRIDGE, Mass. & DANBURY, Conn.-- --Genzyme, a Sanofi company , and the National Organization for Rare Disorders today announced the creation of a fund to pay for standard diagnostic testing for people with mysterious, undiagnosed medical conditions.
via Danbury Newswire http://www.biospace.com/news_story.aspx?StoryID=318775&full=1
via Danbury Newswire http://www.biospace.com/news_story.aspx?StoryID=318775&full=1
No comments:
Post a Comment